原著論文

2016年

【英文論文】

Kajiwara A, Ishizuka T, Yamamura M, Murase M, Koda H, Hirota S, Morita K, Oniki K, Saruwatari J, Nakagawa K.
Prescription of triazolam for the elderly in Japan: A sub-analysis of the drug event monitoring project by the Japan Pharmaceutical Association.
Clin Neuropsychopharmacol Ther. 2016;7:48-53.



Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Matsui K, Hokimoto S.
Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.
Am J Physiol Heart Circ Physiol. 2016;311(6):H1409-H1415.



Tabata N, Sueta D, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.
Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.
PLoS One. 2016;11(11):e0166240.



Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, Kamihashi R, Kita A, Takashima A, Nakagawa K, Yasui-Furukori N, Kadowaki D, Miyata K, Saruwatari J.
The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
Biol Pharm Bull. 2016;39(9):1468-74.



Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Miyazaki H, Yoshida A, Jinnouchi H, Nakagawa K.
Common variants of HNF1A gene are associated with diabetic retinopathy and poor glycemic control in normal-weight Japanese subjects with type 2 diabetes mellitus.
J Diabetes Complications. 2016;S1056-8727(16):30208-2.



Kajiwara A, Kita A, Saruwatari J, Miyazaki H, Kawata Y, Morita K, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.
Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes.
J Diabetes Res. 2016;2016:4626382.



Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N.
Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.
Pharmacogenet Genomics. 2016;26(9):403-13.



Oniki K, Morita K, Watanabe T, Kajiwara A, Otake K, Nakagawa K, Sasaki Y, Ogata Y, Saruwatari J.
The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease
Nutrition & Diabetes. 2016;6:e210.



Tabata N, Hokimoto S, Akasaka T, Yuichiro A, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Koichi K, Kumagae N, Morita K, Oniki K, Nakagawa K, Matsui K, Ogawa H.
Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.
J Cardiol. 2016;67:104-109



Kajiwara A, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Morita K, Oniki K, Saruwatari J & Nakagawa K.
Safety analysis of zolpidem in elderly subjects 80 years of age or older: Adverse event monitoring in Japanese subjects.

Aging & Mental Health.2016;20:611-615.



Noai M, Soraoka H, Kajiwara A, Tanamachi Y, Oniki K, Nakagawa K, Ishitsu T, Saruwatari J.
Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.
Acta Neurol Scand.2016;133:216-223.




Tabata N, Hokimoto S, Akasaka T, Sueta D, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Yamabe H, Matsui K, Ogawa H.
Helicobacter pylori-seropositivity along with pro-inflammatory interleukin-1 polymorphisms correlated with myocardial infarction.
Clin Trials Regul Sci Cardiol.2016;17: 9-14.



Nishizawa A, Inoue T, Ohira S, Takahashi E, Saruwatari J, Iwao K, Tanihara H.
The influence of phacoemulsification on surgical outcomes of trabeculectomy with mitomycin-C for uveitic glaucoma.
PLOS ONE 11.2016;10:e0151947.



Oniki K, Kamihashi R, Tomita T, Ishioka M, Yoshimori Y, Osaki N, Tsuchimine S, Sugawara N, Kajiwara A, Morita K, Miyata K, Otake K, Nakagawa K, Ogata Y, Saruwatari J, Yasui-Furukori N.
Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.
Psychiatry Res.2016;239:190-195.



Akasaka T, Hokimoto S, Sueta D, Tabata N, Sakamoto K, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Ogawa H.
Gender Differences in the Impact of CYP2C19 Polymorphisms and Low-Grade Inflammation on Coronary Microvascular Disorder.
Am J Physiol-Heart Circul Physiol.2016;doi:10.1152/ajpheart.00911.2015.



Tabata N, Hokimoto S, Akasaka T, Sueta D, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogawa H.
Helicobacter Pylori-seropositivity along with genetic and environmental factors predicts clinical outcome after acute coronary syndrome.
Int J Cardiol.2016;212:54-56.




【和文総説】

鬼木健太郎、猿渡淳二.
検査からみる神経疾患 抗てんかん薬のファルマコゲノミクス検査
Clinical Neuroscience 34(10), 1170-1171, 2016



猿渡淳二、鬼木健太郎、平田憲史郎、石津棟暎.
抗てんかん薬のTDMと有効血中濃度域の考え方
臨床化学 45(3), 233-239, 2016